Method Development and Validation in Food and Pharmaceutical Analysis
This reprint covers a wide range of topics including, but not limited to, new analytical and bioanalytical methods relevant to the separation, identification, and determination of substances in pharmaceutics, pharmacokinetics, nanobiotechnology, clinical chemistry, and related disciplines; methods f...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_96768 | ||
| 005 | 20230202 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230202s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-6331-2 | ||
| 020 | |a 9783036563305 | ||
| 020 | |a 9783036563312 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-6331-2 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a GP |2 bicssc | |
| 072 | 7 | |a PN |2 bicssc | |
| 072 | 7 | |a PNF |2 bicssc | |
| 100 | 1 | |a Yoon, In-Soo |4 edt | |
| 700 | 1 | |a Cho, Hyun-Jong |4 edt | |
| 700 | 1 | |a Yoon, In-Soo |4 oth | |
| 700 | 1 | |a Cho, Hyun-Jong |4 oth | |
| 245 | 1 | 0 | |a Method Development and Validation in Food and Pharmaceutical Analysis |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (322 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This reprint covers a wide range of topics including, but not limited to, new analytical and bioanalytical methods relevant to the separation, identification, and determination of substances in pharmaceutics, pharmacokinetics, nanobiotechnology, clinical chemistry, and related disciplines; methods for the identification of bioactive compounds in functional foods and medicinal plants; applications of chromatography and allied techniques in biomedical sciences. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 650 | 7 | |a Chemistry |2 bicssc | |
| 650 | 7 | |a Analytical chemistry |2 bicssc | |
| 653 | |a wild rice | ||
| 653 | |a antioxidant | ||
| 653 | |a macroporous resins | ||
| 653 | |a LC-MS/MS | ||
| 653 | |a phenolics | ||
| 653 | |a procyanidins | ||
| 653 | |a osimertinib | ||
| 653 | |a UPLC-TOF-MS | ||
| 653 | |a rat | ||
| 653 | |a pharmacokinetics | ||
| 653 | |a carbonyl derivatization | ||
| 653 | |a phenylhydrazine | ||
| 653 | |a phenylenediamine | ||
| 653 | |a hydroxylamine | ||
| 653 | |a water analysis | ||
| 653 | |a lipoxidation | ||
| 653 | |a lisdexamfetamine dimesylate | ||
| 653 | |a impurities | ||
| 653 | |a structural elucidation | ||
| 653 | |a forced degradation | ||
| 653 | |a HPLC validation | ||
| 653 | |a chemical constituent profiles of Sinisan | ||
| 653 | |a chinese medicine processing | ||
| 653 | |a chinese medicinal formula compatibility | ||
| 653 | |a Dendropanax morbifera leaf | ||
| 653 | |a xanthine oxidase | ||
| 653 | |a hyperuricemia | ||
| 653 | |a HPLC | ||
| 653 | |a advanced glycation end-products (AGEs) | ||
| 653 | |a Nε-(carboxymethyl) lysine (CML) | ||
| 653 | |a Nε-(carboxyethyl) lysine (CEL) | ||
| 653 | |a antler velvet processing | ||
| 653 | |a UPLC-MS/MS | ||
| 653 | |a Cinnamomum yabunikkei leaf | ||
| 653 | |a elastase | ||
| 653 | |a Citrus junos Seib ex TANAKA | ||
| 653 | |a rhKGF-1 | ||
| 653 | |a rhKGF-2 | ||
| 653 | |a bioactivity | ||
| 653 | |a cell-based bioassay | ||
| 653 | |a method validation | ||
| 653 | |a CYP450 enzyme | ||
| 653 | |a cocktail probe drug | ||
| 653 | |a RT-PCR | ||
| 653 | |a galangin | ||
| 653 | |a affecting factors | ||
| 653 | |a amadori compound | ||
| 653 | |a furosine | ||
| 653 | |a Maillard reaction | ||
| 653 | |a velvet antler processing | ||
| 653 | |a Brazilian green propolis | ||
| 653 | |a phenolic acids | ||
| 653 | |a UPLC-ESI-QTOF-MS | ||
| 653 | |a quantitation | ||
| 653 | |a methodological verification | ||
| 653 | |a Glycyrrhizae Radix extract | ||
| 653 | |a glycyrrhizin | ||
| 653 | |a isoliquiritigenin | ||
| 653 | |a liquiritigenin | ||
| 653 | |a liquiritin | ||
| 653 | |a LC-MS/MS analysis | ||
| 653 | |a desoxo-narchinol A | ||
| 653 | |a Nardostachys jatamansi | ||
| 653 | |a bioavailability | ||
| 653 | |a silybin | ||
| 653 | |a silymarin product | ||
| 653 | |a comparative pharmacokinetics | ||
| 653 | |a ginsenosides | ||
| 653 | |a red ginseng extract | ||
| 653 | |a human | ||
| 653 | |a acanthus ilicifolius herb | ||
| 653 | |a phenylethanoid glycosides | ||
| 653 | |a C.tricuspidata Bureau | ||
| 653 | |a tyrosinase | ||
| 653 | |a dialyzable leukocyte extract | ||
| 653 | |a Transferon® | ||
| 653 | |a complex mixture of peptides | ||
| 653 | |a quality specifications | ||
| 653 | |a biological potency | ||
| 653 | |a development and validation | ||
| 653 | |a Dioscorea nipponica Makino | ||
| 653 | |a steroidal saponin | ||
| 653 | |a HPLC-UV | ||
| 653 | |a UPLC-QTOF/MS | ||
| 653 | |a validation | ||
| 653 | |a osteosarcoma | ||
| 653 | |a apoptosis | ||
| 653 | |a epinastine | ||
| 653 | |a comparison | ||
| 653 | |a SH-1242 | ||
| 653 | |a 2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)ethanone | ||
| 653 | |a HPLC-MS/MS | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6714 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/96768 |7 0 |z DOAB: description of the publication |